Clinical trial
Ketamine for Treatment of Multiple Sclerosis-related Fatigue
NCT03500289 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ketamine for Treatment of Multiple Sclerosis-related Fatigue
- Lead sponsor
- Johns Hopkins University
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- August 10, 2018
- Completion date
- August 30, 2019
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.